OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer Patients’ Perspectives and Experiences of Chemotherapy-Induced Myelosuppression and Its Impact on Daily Life
Robert S. Epstein, Upal Kunal Basu Roy, Matti Aapro, et al.
Patient Preference and Adherence (2021) Vol. Volume 15, pp. 453-465
Open Access | Times Cited: 24

Showing 24 citing articles:

The impact of myelosuppression on quality of life of patients treated with chemotherapy
Jeffrey Crawford, Dana Herndon, Katerina Gmitter, et al.
Future Oncology (2024) Vol. 20, Iss. 21, pp. 1515-1530
Open Access | Times Cited: 9

Antitumor Profile of Combined Matricaria recutita Flower Extract and 5-Fluorouracil Chemotherapy in Sarcoma 180 In Vivo Model
Sara Albuquerque dos Santos, Ricardo Guimarães Amaral, Ariel S. Graça, et al.
Toxics (2023) Vol. 11, Iss. 4, pp. 375-375
Open Access | Times Cited: 16

Dissolving microneedles for melanoma: Most recent updates, challenges, and future perspectives
Yaseen Hussain, Tariq Ali, Linyu Huang, et al.
International Journal of Pharmaceutics (2025), pp. 125382-125382
Closed Access

Trail of acceptance: the experiences and perspectives of chemotherapy adherence among adolescents with cancer
Susilo Harianto, Nursalam Nursalam, Dewi Maryam, et al.
Healthcare in Low-resource Settings (2025)
Open Access

Burden of chemotherapy‐induced myelosuppression among patients with extensive‐stage small cell lung cancer: A retrospective study from community oncology practices
Lowell L. Hart, Augustina Ogbonnaya, Kristen Boykin, et al.
Cancer Medicine (2023) Vol. 12, Iss. 8, pp. 10020-10030
Open Access | Times Cited: 9

Chinese Medicine Combined with Adjuvant Chemotherapy for Improving Myelosuppression in Colorectal Cancer Patients: A Systematic Review and Network Meta-Analysis
Rui Li, Tong Zhang, Shaohua Yan, et al.
Chinese Journal of Integrative Medicine (2024) Vol. 30, Iss. 7, pp. 643-652
Closed Access | Times Cited: 3

Asperuloside alleviates cyclophosphamide‐induced myelosuppression by promoting AMPK/mTOR pathway‐mediated autophagy
Hong Che, Linlin Li, Bingjie Zhao, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 2
Closed Access | Times Cited: 2

TPGS-Modified Long-Circulating Liposomes Loading Ziyuglycoside I for Enhanced Therapy of Myelosuppression
Tingting Song, Hong Wang, Yue Liu, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 6281-6295
Open Access | Times Cited: 15

Budget impact analysis of trilaciclib for decreasing the incidence of chemotherapy-induced myelosuppression in patients with extensive-stage small cell lung cancer in the United States
Ivo Abraham, Amit Goyal, Baris Deniz, et al.
Journal of Managed Care & Specialty Pharmacy (2022) Vol. 28, Iss. 4, pp. 435-448
Closed Access | Times Cited: 8

Development of graphene oxide-based nano-delivery system for natural chemotherapeutic agent (Caffeic Acid)
Shreya Tiwari, Ankush D. Sontakke, Kallolini Baruah, et al.
Materials Today Proceedings (2022) Vol. 76, pp. 325-335
Closed Access | Times Cited: 8

Predictors of Myelosuppression for Patients with Head and Neck Squamous Cell Carcinoma After Induction Chemotherapy
Wenqing Chen, Liang Peng, Xuelan Zeng, et al.
Clinical Medicine Insights Oncology (2024) Vol. 18
Open Access | Times Cited: 1

ANALYSIS OF MYELOSUPPRESSION IN POST-CHEMOTHERAPY BREAST CANCER PATIENTS (A Study at Division of Hematology and Medical Oncology Airlangga University Hospital)
Yulistiani Yulistiani, Febriansyah Nur Utomo, Pradana Zaky Romadhon, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Chemotherapy-Induced Anemia in Adults Incidence and Treatment
S Nasim Ali, Ahmed Farhan Shallal, İbrahim Nazem Qader, et al.
Deleted Journal (2024) Vol. 2, Iss. 2, pp. 34-49
Open Access | Times Cited: 1

Virtual Reality in Cancer Care: Enhancing Knowledge and Reducing Anxiety about Chemotherapy among Patients and Caregivers
Melissa Thomas, A Mousavi Jarrahi, Lauren Dennie, et al.
International Journal of Environmental Research and Public Health (2024) Vol. 21, Iss. 9, pp. 1163-1163
Open Access | Times Cited: 1

Cancer Immunotherapy: Targeting TREX1 Has the Potential to Unleash the Host Immunity against Cancer Cells
Karim Hawillo, Samira Kemiha, Hervé Técher
Onco (2024) Vol. 4, Iss. 4, pp. 322-334
Open Access | Times Cited: 1

Treatment patterns and burden of myelosuppression for patients with small cell lung cancer: A SEER‐medicare study
Robert S. Epstein, Jerrod Nelms, Donald Moran, et al.
Cancer Treatment and Research Communications (2022) Vol. 31, pp. 100555-100555
Open Access | Times Cited: 7

Burden of Chemotherapy-Induced Myelosuppression among Patients with ES-SCLC in US Community Oncology Settings
Jerome H. Goldschmidt, Alisha Monnette, Ping Shi, et al.
Future Oncology (2022) Vol. 18, Iss. 35, pp. 3881-3894
Open Access | Times Cited: 6

Tumor Cell Secretomes in Response to Anti- and Pro-Tumorigenic Agents
Sheng-Zhi Liu, Xun Sun, Kexin Li, et al.
Onco (2021) Vol. 1, Iss. 2, pp. 101-113
Open Access | Times Cited: 7

The Quality of Life Breast Cancer Patients Receiving Chemotherapy and The Factors Affecting It in a Regional Hospital in Gianyar
Agustina Nila Yuliawati, Ni Putu Natasya Dewanti, Pande Made Desy Ratnasari
Pharmacon Jurnal Farmasi Indonesia (2024), pp. 206-218
Open Access

Impact of Chemotherapy on Circulating Lymphocyte Subsets in Lung Cancer Patients
Wei Hong, Xinyuan Zhang, Youkun Qi, et al.
Cancer Management and Research (2024) Vol. Volume 16, pp. 1205-1213
Open Access

Trilaciclib prior to FOLFOXIRI/bevacizumab for patients with untreated metastatic colorectal cancer: phase 3 PRESERVE 1 trial
Heinz‐Josef Lenz, Tianshu Liu, Emerson Y. Chen, et al.
JNCI Cancer Spectrum (2024) Vol. 9, Iss. 1
Open Access

Exploring the acceptability and benefits of group pretreatment consultations for people receiving systemic anticancer therapy
Emma Rowland, Catherine Oakley
Cancer Nursing Practice (2023) Vol. 23, Iss. 5, pp. 20-27
Open Access | Times Cited: 1

Effect of an Ayurveda antidote Dooshivishari Agada in carboplatin induced myelosuppression in Male Wistar rats
Santosh F Patil, Vishalaxi V. Shahapurkar, Pukar Khanal
Journal of Ayurveda and Integrative Medicine (2022) Vol. 13, Iss. 3, pp. 100599-100599
Open Access | Times Cited: 2

Cloning and Overexpression of Staphylococcal Enterotoxin B gene synthetic (SEBsyn) in pET-28a: Pre-development bacterial-toxin therapy for cancer
Achmad Rodiansyah, Marselina Irasonia Tan, Husna Nugrahapraja
International Journal on Advanced Science Engineering and Information Technology (2023) Vol. 13, Iss. 1, pp. 77-77
Open Access

Page 1

Scroll to top